SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-17-008629
Filing Date
2017-09-20
Accepted
2017-09-20 16:11:43
Documents
10
Period of Report
2017-09-19
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT acer_8k.htm 8-K 152151
2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF FORMATION OF THE REGISTRANT. acer_ex31.htm EX-3.1 14841
3 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF FORMATION OF THE REGISTRANT. acer_ex32.htm EX-3.2 11443
4 ACER THERAPEUTICS INC. 2013 STOCK INCENTIVE PLAN. acer_ex103.htm EX-10.3 78267
5 LETTER ON CHANGE IN CERTIFYING ACCOUNTANT acer_ex161.htm EX-16.1 5407
6 PRESS RELEASE ISSUED BY THE REGISTRANT ON SEPTEMBER 19, 2017 acer_ex991.htm EX-99.1 18248
7 IMAGE acer_ex161000.jpg GRAPHIC 27057
8 IMAGE acer_ex161001.jpg GRAPHIC 6859
9 IMAGE acer_ex991000.jpg GRAPHIC 6314
10 IMAGE img001.jpg GRAPHIC 10791
  Complete submission text file 0001654954-17-008629.txt   353172
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 171094148
SIC: 2834 Pharmaceutical Preparations